A Look At SELLAS Life Sciences Group (SLS) Valuation After New IMPACT AML Clinical Study Agreement

SELLAS Life Sciences Group (SLS) has entered an agreement with IMPACT-AML, a pan-European clinical network, to run a new study of its CDK9 inhibitor SLS009 in high-risk newly diagnosed acute myeloid ...
Seeking Alpha

Cornell University College of Agriculture and Life Sciences Study, in partnership with Symbrosia and Danone North America, Aims to Prove Effectiveness of Seaweed Oil Extract ...

The study will aim to prove oil-based seaweed product has the potential to be more effective than existing solutions Dr. Mallory Honan, Symbrosia's product and animal science lead, spoke about the ...

Lir Life Sciences Corp.: LIR Life Sciences Launches Comparative Animal Study to Advance Transdermal Delivery of Second Generation GLP/GIP-based Obesity Therapies

VANCOUVER, BC / ACCESS Newswire / January 15, 2026 / LIR Life Sciences Corp. (CSE:SKNY)(OTC PINK:BBCMF)(Frankfurt:N790, WKN:A41QA9) ("LIR" or the "Company")is pleased to announce the launch of a contr ...
Nasdaq

atai Life Sciences Announces Positive Results from Phase 2a Study of BPL-003 for Treatment-Resistant Depression

Atai Life Sciences announced positive results from Beckley Psytech's Phase 2a study of BPL-003, an adjunctive treatment for patients with treatment-resistant depression (TRD) who are already on ...
Business Wire

Builds Bio+ Announces London/UK Chapter to Boost Transatlantic Life Sciences Collaboration

LONDON--(BUSINESS WIRE)--Builds Bio+, the leading life science membership organization connecting key stakeholders across regional clusters, announces the launch of its London/UK chapter. This ...
Seeking Alpha

atai Life Sciences rises after promising data from depression trial

atai Life Sciences (NASDAQ:ATAI) stock rose after positive results from a mid-stage study exploring a two-dose treatment plan using BPL-003, a nasal spray form of mebufotenin benzoate, for patients ...